Apparatus and method for amyloid beta plaque detection

The method enhances MRI systems with lower field strengths by applying MEFIC processing to achieve rapid and accurate detection of amyloid beta plaques, addressing the limitations of high-field, long-duration MRI systems in diagnosing Alzheimer's disease.

WO2026236192A1PCT designated stage Publication Date: 2026-11-12THE PENN STATE RES FOUND INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/US2026/026663
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-09
Filing Date
2026-05-05
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Current MRI systems for diagnosing Alzheimer's disease require high magnetic field strengths (7T or higher) and long acquisition times, which are impractical for clinical use and not widely available, limiting their applicability for in-vivo human imaging.

Method used

A method and system utilizing lower field strength MRI systems (1.5T, 3T) that enhance signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) through multiple echo frequency-domain contrast (MEFIC) processing, enabling rapid imaging of amyloid beta plaques with high spatial resolution and improved plaque load visualization.

Benefits of technology

Enables accurate and efficient detection of amyloid beta plaques in the brain using 3T MRI scanners within 30 minutes, providing clearer images than conventional methods, suitable for diagnosing Alzheimer's disease and other conditions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure US2026026663_12112026_PF_FP_ABST
    Figure US2026026663_12112026_PF_FP_ABST
Patent Text Reader

Abstract

An MRI data processing method can be performed to quantify and visualize the Amyloid plague load in the human brain. The process can include applying a multiple echo frequency-domain image contrast process to the MRI data obtained from an MRI scan of a subject. The MRI data can be obtained by a 3T MRI scanner in some embodiments. A high signal to noise ratio (SNR) image with a peak image contrast can be obtained for display generation of a high-resolution image for utilization in evaluation of the scanned subject. In some embodiments, the brain of the subject may be scanned and the images can be used to evaluate the condition of the subject's brain.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] APPARATUS AND METHOD FOR AMYLOID BETA PLAQUE DETECTION

[0002] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority to U.S. Provisional Patent Application No. 63 / 802,779, which was filed on May 9, 2025. The entirety of this application is incorporated by reference herein.

[0003] STATEMENT REGARDING FEDERALLY FUNDED RESEARCH

[0004] This invention was made with government support under Grant Nos. AG064486 and AG070088 awarded by the National Institutes of Health. The Government has certain rights in the invention.

[0005] FIELD

[0006] This innovation relates to processes, systems, and devices for the detection of amyloid beta (AP) plaques in the living human brain via a detector device (e.g. a magnetic resonance imaging device, orMRI device, etc.).

[0007] BACKGROUND

[0008] The diagnosis of Alzheimer’s disease (AD) can rely on the imaging of A plaques in a brain using Positron Emission Tomography (PET) with injection of radiotracers or detecting brain morphological changes using MRI. Examples of MRI processing that can be utilized to generate images of a subject can be appreciated from International Publication No. WO 1999 / 030187, the entirety of which is incorporated by reference herein. When using MRI, high spatial resolution images with a high field (7T or higher) MRI system may be needed to provide suitable image quality for evaluation of conditions associated with AD, and with such a system a long acquisition time is needed (often 7 or more hours), which is prohibitively long for in-vivo human imaging studies or clinical utilization. Also, 7T MRI devices are relatively strong field MRI applications and are often not available at many types of care facilities.

[0009] SUMMARY

[0010] It is desired to develop an affordable approach for imaging of Ap plaques with MRI that can utilize lower magnetic field strength systems (e.g. 1.5T, 3T, or 5T MRI systems, etc.) for clinical utilizations. Embodiments of our process, system, and apparatus can be configured to implement such an approach for MRI.The MRI contrast mechanism for imaging Ap plaques can be based on detection of higher iron deposition and shorter T2 in the Ap plaques in the gray matter (GM) tissues. This can reduce the T2* or T2 signal intensity of the Ap plaques, which can produce a hypo intensity in and around the Ap plaques. Therefore, the higher the Ap plaque load within a voxel is, the lower of the T2*- or T2-weighted signal intensity from the voxel will be.

[0011] Embodiments have been developed that can facilitate utilization of MRI and interpretation of MRI data to improve the signal to noise ratio (SNR) and facilitate much shorter acquisition times while also permitting use of lower field strength MRI systems (e.g. 3T or 1.5T field strength MRI systems, etc.).

[0012] We performed evaluations of an exemplary embodiment and found that MRI data collected from the 3T MRI scanner with a 64-channel head coil could be utilized to detect Ap plaques with a sufficient quality to permit diagnosis of AD and other types of diseases by providing improved clarity in imaging and facilitating an easier and more reliable identification of conditions based on the improved images that can be generated via the embodiment.

[0013] Embodiments can permit imaging to provide a greater contrast to noise ratio (CNR) for T2* or T2 processing of the image as compared to conventional gradient-recalled echo (GRE) imaging with single echo. The greater CNR that can be provided can provide for high spatial resolution for in vivo imaging of an animal brain at 3T, for example. Prominent T2 or T2* contrast in the brain images taken via MRI imaging systems (e.g. 3T or 1.5T) can facilitate detection of Ap plaques and an evaluation of those plaques and how that may indicate that a patient or subject has a medical condition (e.g. AD, etc ).

[0014] We have found that embodiments can provide high spatial resolution to visualize plaque load in vivo on a 3T MRI scanner within image acquisition times of less than 30 mins, which can be suitable for human or other animal in vivo use. Data from experimentation we have conducted shows that high CNR images can be obtained via embodiments so that clusters of Ap plaques within a voxel can be delineated with their morphological, anatomical, and pathological features. Also, the contributions of the confounding factors to the T2* contrast can be utilized to provide valuable information on the associated pathological changes with AD so that embodiments can permit pathological changes associated with Ap load in aging and AD to be visibly observed in images generated via a 3T MRI system in aging and AD patients, which is of more informative than PET Ap mapping images.In a first aspect, a process for transforming magnetic resonance imaging (MRT) data into a quantitative map for Amyloid beta (A0) plaques load in human cortex can be provided. The process can include acquiring T2*- or T2-weighted MRI data obtained via an MRI scan of a head of a human subject to provide a T2*- or T2-weighted image contrast for forming image data of a brain within the head for sending to a display device for display of an image generatable from the image data, normalizing a signal intensity of the image data by a signal intensity of a preselected region of interest (ROI) in the image or by an image intensity for the image via use of at least one fiducial marker, segmenting the brain image into grey matter (GM), white matter (WM) and cerebral spinal fluid (CSF), removing pixels in the image in GM containing blood vessels via a maximum projection method and a minimum projections method, and providing the image having the GM, WM, and CSF segments and the removed pixels to display an image that identifies A0 plaques in the image such that a signal intensity of pixels of the image containing AP plagues in the GM is negatively proportional to an Ap plague load within the pixel.

[0015] Embodiments of the process can also include other steps. For example, in a second aspect, the process can also include applying a multiple echo frequency-domain contrast (MEFIC) acquisition method to the image data that includes acquiring multi echo MRI data, transforming the multiple echoes MRI data with Fourier transform (FT) with respect to echo time (TE) of the MRI scan, and selecting a peak image from the transformed images set with the highest signal to noise ratio (SNR).

[0016] In some embodiments, the multiple echoes can include gradient-echoes for T2* relaxation or spin-echoes for T2 relaxation.

[0017] In some embodiments, the MEFIC acquisition method can also include adjusting the transformed MRI data for the multiple echoes to provide a peak image contrast for each image of the MRI data for the multiple echoes and / or generating an image of a brain of the head of the subject based on at least one of the adjusted images of the MRI data for the multiple echoes.

[0018] In some embodiments, the applying of the MEFIC acquisition method can occur via an image generation device having a processor connected to a non-transitory computer readable medium that is communicatively connectable to an MRI scanner that creates the MRI scan data of the MRI scan. The image generation device can be communicatively connectable to at least one user device in some embodiments. The user device(s) can include a laptop computer, a smart phone, or a tablet or other type of user device (e.g. desktop computer, etc.).In some embodiments, the MEFIC acquisition method can be defined in code stored in the non-transitory computer readable medium of the image generation device so that the MEFIC process is performed by the image generation device when the processor of the image generation device runs the code.

[0019] In a third aspect, the method of the first aspect can include one or more features of the second aspect and / or other features or elements. Examples of the other features or elements can be appreciated from the discussion of exemplary embodiments provided herein, for instance.

[0020] In a fourth aspect, a non-transitory computer readable medium having code stored thereon that defines a multiple echo frequency -domain contrast (MEFIC) process for manipulating magnetic resonance imaging (MRI) scan data provided by an MRI scanner can be provided. The MEFIC process can be performable by a device having a processor that runs the code. The process can include applying the MEFIC process to the MRI scan data obtained via an MRI scan of a head of a subject to provide a peak image contrast having a signal to noise ratio (SNR) that is over 50 for forming image data for sending to a display device for display of an image generatable from the image data. In some embodiments, the SNR can range from 50-150, 100-150, or 50-120, for example. In other embodiments, the SNR can be over 50 and less than 200 or at least 100 and less than 250, for example.

[0021] In some embodiments, the MEFIC process that is defined can include the method of the first aspect, second aspect, and / or third aspect discussed above, for instance.

[0022] In some embodiments, the MEFIC process can include performing a Fourier transform for multiple echoes acquired with respective to echo time of the MRI scan. The multiple echoes can include gradient-echoes for T2* or spin-echoes for T2 contrast, for example.

[0023] The MEFIC process can also include adjusting the transformed MRI scan data for the multiple echoes to provide a peak image contrast for each image of the MRI scan data for the multiple echoes. The MEFIC process defined by the code can also include generating an image of a brain of the head of the subject based on at least one of the adjusted images of the MRI data for the multiple echoes.

[0024] In a fifth aspect, a system for magnetic resonance imaging (MRI) data adjustment for generation of MRI imaging to illustrate a scanned brain of a subject can be provided.

[0025] Embodiments of the system can utilize an embodiment of the method of the first aspect, secondaspect, third aspect, and / or below discussed sixth aspect and may also utilize the non-transitory computer readable medium of the fourth aspect.

[0026] Embodiments of the system can include an MRI scanner that is configured to emit a field strength of 7T or less than 7T and an image generation device (IGD) communicatively connectable to the MRI scanner to receive MRI scan data of the subject, the IGD having a processor. The IGD can be configured to apply a multiple echo frequency-domain contrast (MEFIC) process to MRI data obtained via an MRI scan of the MRI scanner to provide a peak image contrast having a signal to noise ratio (SNR) that is over 50 for forming image data for sending to a display device for display of an image generatable from the image data.

[0027] In some embodiments, the SNR can range from 50-150, 100-150, or 50-120, for example. In other embodiments, the SNR can be over 50 and less than 200 or at least 100 and less than 250, for example.

[0028] In some embodiments, the IGD includes non-transitory memory having code stored thereon that defines the MEFIC process.

[0029] In some embodiments, the MRI image data can be acquired in 7T MRI scanner, a 5T MRI scanner, a 3T MRI scanner, or a 1.5T MRI scanner.

[0030] In a sixth aspect, a process for transforming magnetic resonance imaging (MRI) data can be provided. The process can include applying a multiple echo frequency-domain contrast (MEFIC) process to MRI data obtained via an MRI scan of a head of a subject to provide a peak image contrast having a signal to noise ratio (SNR) that is over 50 for forming image data for sending to a display device for display of an image generatable from the image data.

[0031] In some embodiments, the MEFIC process can include performing a Fourier transform the multiple echoes acquired during each echo time (TE) of the MRI scan to transform the MRI data for the multiple echoes into the frequency domain. The multiple echoes can include gradient-echoes for T2* contrast or spin-echoes for T2 contrast.

[0032] In some embodiments, the MEFIC process can also include adjusting the transformed MRI data for the multiple echoes to provide a peak image contrast for each image of the MRI data in a frequency domain and / or generating an image of a brain of the head of the subject based on at least one of the adjusted images of the MRI data for the multiple echoes.

[0033] In some embodiments, the applying of the MEFIC process can occur via an image generation device having a processor connected to a non-transitory computer readable mediumthat is communicatively connectable to an MRT scanner that creates the MRI scan data of the MRI scan. In some embodiments, the image generation device can be communicatively connectable to at least one user device (e.g. a laptop computer, a smart phone, a desktop computer, a personal computer, a tablet, etc.).

[0034] In some embodiments, the MEFIC process can be defined in code stored in the non-transitory computer readable medium of the image generation device so that the MEFIC process is performed by the image generation device when the processor of the image generation device runs the code.

[0035] Other details, objects, and advantages of our material, apparatus, process, and system as well as methods of making and using the same will become apparent as the following description of certain exemplary embodiments thereof proceeds.

[0036] BRIEF DESCRIPTION OF THE DRAWINGS

[0037] The above and other objects, aspects, features, advantages, and possible applications of embodiments of the present innovation will be more apparent from the following more particular description thereof, presented in conjunction with the following drawings. Like reference numbers used in the drawings may identify like components.

[0038] FIG. 1 shows a photograph of a GRE image and an MRI image obtained via use of an exemplary embodiment of the invention.

[0039] FIG. 2 shows MRI images obtained via use of an exemplary embodiment of the invention. The images include an A0- subject image and an A0+ subject image. As can be seen from FIG. 2, the normal contrast between GM and WM seen in the A(3- subject is diminished in the A + subject due to the A load in the GM of the A + patient that can be identified from the image of the Ap+ patient.

[0040] FIG. 3 shows a series of images of T2* -weighted MRI via an exemplary embodiment (left column, MEFIC T2*WI), an MRI- A0 Map (middle column) via a conventional MRI imaging approach, and a PET image (right column) produced as a PET Ap Map via a PET based imaging approach. The images include images for an A + subject and an A - subject. The MRI-Ap and PET-Ap Maps have various regions that indicate voxels with a standardized uptake value ratio (SUVr) that is greater than or equal to 1.11. As the PET radioactive tracer is taken up by the WM ubiquitously, to show the Ap more specifically in the GM pathology, the WM was masked out from the PET map. The correspondence between the MRI and PET Ap maps isevident and the MRI Ap map appears to be less dense than the PET Ap map due to the accumulative effect of the Ap load by lower spatial resolution of PET (slice thickness PET is 5 mm vs. the slice thickness of the MRI being 0.7 mm).

[0041] FIG. 4 is a series of images that include portions of the images included in FIG. 3 with those images being enlarged or zoomed for more detailed visualization. Voxels between the GM and WM boundary in the MRI and PET Ap maps are likely due to the signal contamination of sub-cortical WM (as identified by the arrows).

[0042] FIG. 5 is a schematic diagram of an exemplary embodiment of a system that can utilize an embodiment of our process.

[0043] FIG. 6 is a flow chart illustrating an exemplary embodiment of our process for utilizing MRI data to generate one or more images that can better illustrate the presence of Ap plaques. The exemplary process shown in FIG. 6 illustrates exemplary steps SI, S2, S3, and S4.

[0044] FIG. 7 is a schematic illustration illustrating an exemplary embodiment of our process for utilizing MRI data to generate one or more images that can identify the presence of Ap plaques.

[0045] FIG. 8 is a series of graphs D, E, and F that illustrates an exemplary embodiment of the timing sequence for MRI scanner to acquire the image for MEFIC (D) and an exemplary embodiment of our process (E and F) for utilizing the MRI data to generate one or more images that can better illustrate the presence of Ap plaque loads by illustrating image changes.

[0046] DETAILED DESCRIPTION FIG. 5 illustrates an MRI device that can include at least one coil that can be utilized to emit a radiofrequency (RF) electromagnetic field to collect MRI data. This data can be transmitted to an image generation device (IGD). The IGD can have a processor connected to a non-transitory computer readable medium that can have at least one application stored thereon as well as one or more data stores. The application(s) can include code stored in the non-transitory computer readable medium that can be executed by the processor so the IGD can implement a pre-defined method defined by the code for generation of one or more images using the received MRI data. The image data that can be generated by the IGD can be displayed via a display device that can be communicatively connected to the IGD or can be transmitted to a user device (UD) for display. The UD can be a laptop computer, personal computer, tablet, or other type of communication terminal device, for example.The TGD can also be communicatively connected to one or more input devices and / or output devices, one or more sensors of an MRI device, or other element of an MRI device. In some embodiments, the IGD can be a cloud based service hosting device (e.g. cloud based server, workstation, etc.). In other embodiments, the IGD can be a local computer device that can receive data from the MRI device and can also provide data via one or more communicative connections to a display and / or UD via a local area network or other suitable type of network connection or direct communicative connection.

[0047] The code that defines the image generation methodology to be implemented via the processor of the IGD can be configured to implement a pre-selected or pre-defined image generation process. An embodiment of such a process can be a multiple echo frequency-domain image contrast (MEFIC) process, for example. Such a process can be defined to utilize multiple echoes acquired during TE of an MRI scan (e.g. the gradient-echo for T2* processing or the spin-echo for T2 processing). The MEFIC can also include performing a Fourier transform along the echo dimension and using such transformed data to form a peak image contrast. Such processing can provide a high SNR for 3T MRI devices that may be used as the MRI scanner in clinical situations, for example. Such image contrast can result in the generation of an image that can allow for easier identification of A0 plaques utilizing scanner image data acquired in less than an hour (e.g. less than 1 hour, less than 15 minutes, less than 30 minutes, between 10 and 30 minutes, between 10 and 20 minutes, etc.).

[0048] Embodiments can utilize a pre-defined MEFIC process that can utilize the collected multiple echo images obtained during this idled TE period. These echo images can be integrated by a Fourier transform (FT) operation, which can result a significant increase in SNR without an increase in overall imaging time (e.g. overall MRI scanning time). Such processing can also occur so an optimal T2* or T2 weighted contrast can be obtained for the generated images.

[0049] The SNR can be 50 or over 50 (e.g. 100 or over 100) in some embodiments. The process can be performed so that the increased SNR can be adapted to be another type of pre-selected SNR level as well (e.g. over 100, between 50 and 150, over 75, between 75 and 200, be over 50 and less than 200, or be at least 100 and also less than 250, etc.).

[0050] In some embodiments, multiple echoes can be acquired during TE of an MRI scan (e.g. gradient-echo for T2* weighting or spin-echo for T2 weighting). A Fourier transform alongecho dimension can then be performed on the acquired echoes. An example of such a process can be appreciated from form FIG. 8 and mathematically describe by the equation below:

[0051] I(co) = |F{ S(TE)} | = So ■ T2 / (1 + CO2T22)1 / 2

[0052] The Fourier transformed image data, or MRI scan data, may subsequently be adjusted to provide a peak image contrast. A formula for to define such an approach is provided below:

[0053] Al / 1 oc (T - T2J) / T2J

[0054] In the above formulas, I(co) is the image intensity of MEFIC, where F represents Fourier transform operator, TE is the echo time, S is the MRI signal at different TE , T2 is transverse relaxation time constant, co is Larmor frequency of the MRI system, I is MRI image intensity after Fourier transformation, Al is the image intensity difference between the two tissue types, (i and j) with corresponding to transverse relaxation time T21and T2’.

[0055] An example of processing to generate suitable images based on MRI scan data from a 3T MRI scanner or other lower field strength scanner can be appreciated from FIG. 6. For example, in a first step SI, MRI signal data can be collected via an MRI scan after the MRI scanner has various operational parameters settings defined for repetition time (TR), echo time (TE), flip angle (FA), resolution, slice oversampling, and the GeneRalized Autocalibrating Partial Parallel Acquisition (GRAPPA) factor. For example, the GRAPPA factor can be between 2 and 4, between 2 and 6, or other suitable number (e.g. 2, 3, 4, 5, 6, a value between 2 and 6, etc.), the TE can be set to be between 5 ms and 7 ms (e g. 6.43 ms), a distance between echoes can be defined to be between 5 and 5.2 ms (e.g. 5.06 ms), the FA can be between 5° and 15° (e g. 10°), the TR can be between 50 ms and 70 ms (e.g. 60 ms), and the slice oversampling can be between 12% and 20% (e.g. 16% or 16.47%). The resolution can also be defined to be a suitable value or resolution number, such as, for example 0.4 x 0.4 x 0.7 mm3resolution or 0.5 x 0.5 x 0.8 mm3resolution, or other suitable resolution.

[0056] In a second step S2, the collected MRI signal data can be sent to an imaging generation device (IGD) for processing. For instance, the MRI scanner can transmit that collected data to the IGD or a sensor or detector of the MRI scanner can transmit such data to the IGD. In a third step S3, the IGD can apply a pre-defined MEFIC process to the MRI signal data for the multiple echoes can be acquired during TE of an MRI scan (e.g. gradient-echo for T2* or spin-echo for T2) to perform a transformation of that data and subsequent processing of the scan data to obtain a peak image contrast for the images of the scan data. In a fourth step S4, the generated imagedata obtained via the MEFIC process can be provided for display generation of the image(s). The data can be provided for display on a display of the IGD or can be communicated to a user device for display on a display unit (e.g. screen, liquid crystal display, touch screen, monitor, etc.) of the user device UD. The user device UD can be communicatively connected to the IGD via a direct wired connection or via a network connection (e.g. wireless local area network connection, wide area network connection, etc.) to receive the image data for generation of the images, for example. A user may observe the displayed images and evaluate the images to determine whether the subject who was scanned may have AD or other type of disease.

[0057] In some embodiments, the MRI scanning of a subject in the first step SI can take less than 1 hour. For instance, the scanning time may take between 10 minutes and 20 minutes, between 5 minutes and 25 minutes, or other suitable time. The MRI scanner utilized for the scanning can utilize a relatively low field strength of 3T or less than 3T in some embodiments.

[0058] In the third step S3, the MEFIC processing can be defined to include a number of processing routines for processing the MRI scan data received by the IGD. In some embodiments, the MEFIC processing can include acquiring the T2*- or T2-weighted MRI data obtained via the MRI scan of a head of a subject to provide a T2* image contrast for forming image data of a brain within the head for sending to a display device for display of an image generatable from the image data. A signal intensity of an image of the image data can be normalized by a signal intensity of a pre-selected region of interest (RO I) in the image or by an image intensity for the image via use of at least one fiducial marker. Examples of at least one fiducial maker(s) can include tubes of water-based solutions with known T2* relaxations mounted on the human subject head during image acquisition.

[0059] The image can subsequently be segmented into grey matter (GM), white matter (WM) and cerebral spinal fluid (CSF). Pixels in the image in GM containing blood vessels can then be removed via a maximum projection method and a minimum projections method. The image can then be provided having the GM, WM, and CSF segments and the removed pixels to display an image that identifies A0 plaques in the image such that a signal intensity of pixels of the image containing Ap plagues in the GM is negatively proportional to an Ap plague load within the pixel load in the generated image, which can be generated as a PET image or an image in another type of image format.FIG. 7 and FIG 8 further illustrate examples of this type of image data processing. For example, as may be appreciated from FIG. 8, two image sets can be minimally needed to produce an MRI A0 map. In Box A of FIG. 7, data acquisition of Tl-weighted and high-resolution T2*-weighted image with MEFIC or with any other MRI methods from the subject’s brain can occur to obtain this image data. In Box B of FIG. 7, co-regi strati on and segmentation of T2* -weighted image into gray matter (GM), white matter (WM) can be performed with the aid of Tl-weighted image data. The GM image signal can then be moralized by the mean signal of the GM and WM of each subject. In Box C of Fig. 7, the voxel intensity of the normalized GM image can be correlated to a PET-SUVr-to-MRI Ap lookup table to produce the subject’s A load map (the MRI Ap Map shown in FIG. 7). The PET-SUVr-to-MRI Ap lookup table can be produced as a result of a large cohort study in which both PET- Ap scan and MRI scans are acquired from the same subject to provide baseline comparison data that may be utilized for correlating the voxel intensity of the normalized GM image data. The correlation of the voxel intensity can be performed such that the higher the Ap plaque load within a voxel, the lower of the T2*- or T2-weighted signal intensity from the voxel will be. Similarly, the lower the Ap plaque load within a voxel, the higher the T2*- or T2-weighted signal intensity from the voxel will be.

[0060] The MRI Ap lookup table that may be utilized can be based on a number of scans from different subjects (e.g. a table that is based on PET-SUVr scans and MRI Ap scans from different subjects are utilized to create the lookup. The table can be based on scan data of multiple subjects (e.g. 30 subjects, 50 subjects, 100 subjects, 1,000 subjects, etc.).

[0061] FIG. 8 further illustrates how the MEFIC processing can be performed along with timing for that processing. As may be seen from FIG. 8, the image data processing can result in the image intensity contrast to noise ratio (CNR) being significantly improved. The timing associated with that processing may also be appreciated from FIG. 8, which shows how the radio frequency (RF) signal of the MRI scan data can be read, complied into a phase, and sliced for providing a signal that can be processed to alter the image data from the MRI scan to provide an image with greater image intensity CNR.

[0062] FIG. 8 illustrates a timing diagram D for the sequence used for acquisition of MEFIC image generation. Images E illustrate the intensity multi-echo for images of an animal brain (mouse brain) before and after Fourier transform (FT) occurs. Graphs F of FIG. 8 are thecorresponding pixel signal intensity distribution of the multi -echo images E before and after FT. The arrow ARW extending from images E to the peak of the multi-echo frequency domain intensity graph included in graphs G of FIG. 8 indicates the peak image that yields the strongest signal in the MEFIC image set for this particular example.

[0063] Studies have shown that florbetapir uptake is higher in white matter compared to gray matter in the brain of animals (e.g. human brains). The reason for this non-specific binding in white matter is not fully understood, but one hypothesis is that slower cerebral blood flow in white matter leads to slower clearance of florbetapir. Florbetapir retention in white matter may be related to myelin integrity and changes in florbetapir uptake in white matter have been linked to cognitive decline and tau accumulation. Understanding florbetapir uptake in white matter is important for accurate interpretation of PET scans and MRI scans and for potentially using florbetapir as a marker of myelin integrity and related neurological processes associated with florbetapir uptake in white matter. Embodiments of the process can facilitate improved identification and monitoring of florbetapir uptake in white matter to help provide improved scan image data and scan mapping data that can be displayed to a clinician for use in diagnosing a neurological condition (e.g. Alzheimer’s Disease, etc.).

[0064] EXAMPLES MRI data was collected using a Siemens Prisma-FIT™ 3T MRI scanner with a 64-channel head coil. Three dimensional (3D) data was collected for utilization of an embodiment of our processing scheme via this MRI scanner with the following parameters:

[0065] Repetition time (TR) = 60 ms,

[0066] Echo time (TE) = 6.43 ms to 51.97 ms with 5.06 ms distance between echoes;

[0067] Flip angle (FA) was 10°

[0068] Spatial resolution was 0.4 x 0.4 x 0.7 mm3,

[0069] Slap oversampling was 16.7%,

[0070] GeneRalized Autocalibrating Partial Parallel Acquisition (GRAPPA) factor was 2, and the scan time was 12 minutes and 49 seconds (12:49, e.g. the duration of a scan was less than 13 minutes).

[0071] For the PET scanning that was utilized in the experimental work, a 370 MBq (10 mCi) dose of Florbetapir™ (Amyvid) was injected 30 minutes before a PET scan was performed usinga Siemens™ Biograph™ mCT 20 PET / CT scanner with 5.5 mm for the axial (Z), and 5.9 mm for the transverse (XY).

[0072] The experimental work included image acquisition for eighteen (18) mild cognitive impaired (MCI) subjects and 12 cognitively normal control (NC) subjects. Clinca™ software was utilized to calculate the SUVr. The PET images were registered to the T1 -weighted MRI using FreeSurfer™ and the intensity was normalized using the pons and cerebellum in the Montreal Neurological Institute (MNI) coordinate system. The PET, Tl-weighted (Tlw), and images utilizing an embodiment of our process (MEFIC) were co-registered in the patients’ native space.

[0073] Figures 1-4 show a compare and contrast of the images that were obtained from this experimental work. The images show that embodiments of our process can provide enhanced image quality for enhanced disease diagnosis in a quicker, more efficient process as compared to other conventional approaches.

[0074] For instance, as can be seen from FIG. 1, imaging utilizing an embodiment of our process (MEFIC) can provide a greater than lOx T2* CNR than GRE imaging. This can allow for high spatial resolution of human brain imaging in vivo at 3T.

[0075] FIG. 2 shows images of a T2* MRI via use of an embodiment (MEFIC) from A + and Ap- subjects. The prominent contrast between the grey matter and the white matter in the Ap-subject diminished in the Ap+ subject mainly due to the Ap load in the grey matter of the subject.

[0076] FIG. 3 shows a correlation between The MRI- Ap and PET- Ap maps. For instance, these maps have various regions that indicate voxels with a standardized uptake value ratio (SUVr) that is greater than or equal to 1.11 as Ap+. As the PET radioactive tracer is taken up by the WM ubiquitously, the WM was masked out from the PET map. The correspondence between the MRI and PET Ap maps is evident and the MRI Ap map appears to be less dense than the PET Ap map due to the accumulative effect of the Ap load by lower spatial resolution of PET (slice thickness PET is 5 mm vs. the slice thickness of the MRI being 0.7 mm).

[0077] FIG. 4 include zoomed in portions of the images included in FIG. 3 to better illustrate the voxels in the GM-WM boundary in the MRI and PET Ap maps, which are likely due to the signal contamination of sub-cortical WM (as identified by the arrows).The results of the conducted experimentation show that an embodiment of our process can provide better image rendering via an MRI 3T scanner to facilitate a significant improvement in diagnosing conditions association with A plaques (e.g. AD). For instance, pathological changes associated with Ap load can be more easily identified in appreciated via images rendered from 3T MRI data utilizing an embodiment of our process as compared to a conventional approach utilizing PET and PET Ap mapping.

[0078] Embodiments can be provided so that Ap plaques can be detected with high resolution MEFIC (T2*) in images generated from MRI scans of a living human brain. The sensitivity for detection of the AP plaques can be higher with higher spatial resolution. The specificity for detection of Ap plaques can be high with high-resolution T2* image that can be generated via the MEFIC processing to help to remove / separate confounds of AD comorbid pathologies.

[0079] Embodiments can utilize the dilution effect (e.g. intravoxel averaging) and can be adapted to reduce confounds such as small veins and microbleeds so that they are no longer discernable from plaques (e.g. false positives can be removed via filtering in processing) and white matter contamination can also be removed.

[0080] Also, lower resolution images or image maps can be reconstructed so that they may be useful for clinical radiology for delineation of normal aging and early AD. We have surprisingly found that the obtaining of a high SNR via the MEFIC processing can be needed for both maximizing resolution & minimizing MRI scan time.

[0081] It should be understood that modifications to the embodiments disclosed herein can be made to meet a particular set of design criteria. For instance, the number of or configuration of components or parameters may be used to meet a particular objective.

[0082] It will be apparent to those skilled in the art that numerous modifications and variations of the described examples and embodiments are possible in light of the above teachings of the disclosure. The disclosed examples and embodiments are presented for purposes of illustration only. Other alternative embodiments may include some or all of the features of the various embodiments disclosed herein. For instance, it is contemplated that a particular feature described, either individually or as part of an embodiment, can be combined with other individually described features, or parts of other embodiments. The elements and acts of the various embodiments described herein can therefore be combined to provide further

[0083] embodiments.It is the intent to cover all such modifications and alternative embodiments as may come within the true scope of this invention, which is to be given the full breadth thereof. Additionally, the disclosure of a range of values is a disclosure of every numerical value within that range, including the end points. Thus, while certain exemplary embodiments of the apparatus and process and / or utilization and methods of making and using the same have been discussed and illustrated herein, it is to be distinctly understood that the invention is not limited thereto but may be otherwise variously embodied and practiced within the scope of the following claims.

Claims

What is claimed is:

1. A process for transforming magnetic resonance imaging (MRI) data into a quantitative map for Amyloid beta (A0) plaques load in human cortex, the process comprising:acquiring T2*- or T2-weighted MRT data obtained via an MRI scan of a head of a human subject to provide a T2*- or T2-weighted image contrast for forming image data of a brain within the head for sending to a display device for display of an image generatable from the image data;normalizing a signal intensity of the image data by a signal intensity of a pre-selected region of interest (ROI) in the image or by an image intensity for the image via use of at least one fiducial marker;segmenting the brain image into grey matter (GM), white matter (WM) and cerebral spinal fluid (CSF);removing pixels in the image in GM containing blood vessels via a maximum projection method and a minimum projections method,providing the image having the GM, WM, and CSF segments and the removed pixels to display an image that identifies A0 plaques in the image such that a signal intensity of pixels of the image containing A0 plagues in the GM is negatively proportional to an A0 plague load within the pixel.

2. The process of claim 1, comprising:applying a multiple echo frequency-domain contrast (MEFIC) acquisition method to the image data that includes:acquiring multi echo MRI data;transforming the multiple echoes MRI data with Fourier transform (FT) with respect to echo time (TE) of the MRI scan;selecting a peak image from the transformed images set with the highest signal to noise ratio (SNR).

3. The process of claim 2, wherein the multiple echoes include gradient-echoes for T2* relaxation or spin-echoes for T2 relaxation.

4. The process of claim 2, wherein the MEFTC acquisition method also includes adjusting the transformed MRI data for the multiple echoes to provide a peak image contrast for each image of the MRI data for the multiple echoes.

5. The process of claim 4, comprising:generating an image of a brain of the head of the subject based on at least one of the adjusted images of the MRI data for the multiple echoes.

6. The process of claim 2, wherein the applying of the MEFIC acquisition method occurs via an image generation device having a processor connected to a non-transitory computer readable medium that is communicatively connectable to an MRI scanner that creates the MRI scan data of the MRI scan.

7. The process of claim 6, wherein the image generation device is communicatively connectable to at least one user device.

8. The process of claim 7, wherein the at least one user device is a laptop computer, a smart phone, or a tablet.

9. The process of claim 6, wherein the MEFIC acquisition method is defined in code stored in the non-transitory computer readable medium of the image generation device so that the MEFIC process is performed by the image generation device when the processor of the image generation device runs the code.

10. A non-transitory computer readable medium having code stored thereon that defines a multiple echo frequency-domain contrast (MEFIC) process for manipulating magnetic resonance imaging (MRI) scan data provided by an MRI scanner, the process being performable by a device having a processor that runs the code, the process comprising:applying the MEFIC process to the MRI scan data obtained via an MRI scan of a head of a subject to provide a peak image contrast having a signal to noise ratio (SNR) that is over 50 for forming image data for sending to a display device for display of an image generatable from the image data.

11. The non-transitory computer readable medium of claim 10, wherein the MEFIC process includes performing a Fourier transform for multiple echoes acquired with respective to echo time of the MRI scan.

12. The non-transitory computer readable medium of claim 11, wherein the multiple echoes include gradient-echoes for T2* or spin-echoes for T2 contrast.

13. The non-transitory computer readable medium of claim 12, wherein the MEFIC process also includes adjusting the transformed MRI scan data for the multiple echoes to provide a peak image contrast for each image of the MRI scan data for the multiple echoes.

14. The non-transitory computer readable medium of claim 10, wherein the MEFIC process defined by the code also includesgenerating an image of a brain of the head of the subject based on at least one of the adjusted images of the MRI data for the multiple echoes.

15. A system for magnetic resonance imaging (MRI) data adjustment for generation of MRI imaging to illustrate a scanned brain of a subject, the system comprising:an MRI scanner that is configured to emit a field strength of 7T or less than 7T;an image generation device (IGD) communicatively connectable to the MRI scanner to receive MRI scan data of the subject, the IGD having a processor, the IGD configured to apply a multiple echo frequency-domain contrast (MEFIC) process to MRI data obtained via an MRIscan of the MRT scanner to provide a peak image contrast having a signal to noise ratio (SNR) that is over 50 for forming image data for sending to a display device for display of an image generatable from the image data.

16. The system of claim 15, wherein the IGD includes non-transitory memory having code stored thereon that defines the MEFIC process.

17. The process of claim 1, wherein the MRI image data are acquired in 7T MRI scanner, a 5T MRI scanner, a 3T MRI scanner, or a 1.5T MRI scanner.

18. A process for transforming magnetic resonance imaging (MRI) data, the process comprising:applying a multiple echo frequency-domain contrast (MEFIC) process to MRI data obtained via an MRI scan of a head of a subject to provide a peak image contrast having a signal to noise ratio (SNR) that is over 50 for forming image data for sending to a display device for display of an image generatable from the image data.

19. The process of claim 18, wherein the MEFIC process includes performing a Fourier transform the multiple echoes acquired during each echo time (TE) of the MRI scan to transform the MRI data for the multiple echoes into the frequency domain.

20. The process of claim 19, wherein the multiple echoes include gradient-echoes for T2* contrast or spin-echoes for T2 contrast.

21. The process of claim 19, wherein the MEFIC process also includes adjusting the transformed MRI data for the multiple echoes to provide a peak image contrast for each image of the MRI data in a frequency domain.

22. The process of claim 21, comprising:generating an image of a brain of the head of the subject based on at least one of the adjusted images of the MRI data for the multiple echoes.

23. The process of claim 18, wherein the applying of the MEFTC process occurs via an image generation device having a processor connected to a non-transitory computer readable medium that is communicatively connectable to an MRI scanner that creates the MRI scan data of the MRI scan.

24. The process of claim 23, wherein the image generation device is communicatively connectable to at least one user device.

25. The process of claim 24, wherein the at least one user device is a laptop computer, a smart phone, or a tablet.

26. The process of claim 23, wherein the MEFIC process is defined in code stored in the non-transitory computer readable medium of the image generation device so that the MEFIC process is performed by the image generation device when the processor of the image generation device runs the code.